|
SNHG4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.15250064836437E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.52000000042518E-07 |
| Normal-vs-Stage2 |
7.566500E-04 |
| Normal-vs-Stage3 |
2.54669999999457E-06 |
| Normal-vs-Stage4 |
1.042930E-04 |
| Stage1-vs-Stage2 |
1.848410E-01 |
| Stage1-vs-Stage3 |
2.021800E-01 |
| Stage1-vs-Stage4 |
5.225600E-02 |
| Stage2-vs-Stage3 |
6.149200E-01 |
| Stage2-vs-Stage4 |
5.963800E-01 |
| Stage3-vs-Stage4 |
2.760800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.70110053715678E-10 |
| Normal-vs-AfricanAmerican |
1.535900E-03 |
| Normal-vs-Asian |
9.485700E-02 |
| Caucasian-vs-AfricanAmerican |
6.232400E-01 |
| Caucasian-vs-Asian |
2.521400E-01 |
| AfricanAmerican-vs-Asian |
2.278200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.69209987635577E-10 |
| Normal-vs-Female |
2.20829999997285E-06 |
| Male-vs-Female |
2.096400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.997600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.50569999696404E-08 |
| Normal-vs-Age(61-80Yrs) |
5.43579999900956E-08 |
| Normal-vs-Age(81-100Yrs) |
1.572190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.823200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.888400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.115400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.181600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.341800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.550400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.620200E-01 |
| Normal-vs-Grade 2 |
1.60966999999124E-05 |
| Normal-vs-Grade 3 |
2.22520002424176E-09 |
| Normal-vs-Grade 4 |
9.84950000000318E-05 |
| Grade 1-vs-Grade 2 |
6.188100E-02 |
| Grade 1-vs-Grade 3 |
3.342400E-03 |
| Grade 1-vs-Grade 4 |
1.778970E-03 |
| Grade 2-vs-Grade 3 |
6.004100E-02 |
| Grade 2-vs-Grade 4 |
2.028100E-02 |
| Grade 3-vs-Grade 4 |
1.265390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.77549999994476E-07 |
| Normal-vs-ccB subtype |
2.12909999963706E-07 |
| ccA subtype-vs-ccB subtype |
3.344200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.08070000515559E-08 |
| Normal-vs-N1 |
1.824170E-03 |
| N0-vs-N1 |
5.024400E-02 |
|
|
